Hasil Pencarian (2)
AT-7519
DB08142
small molecule | CAS: 844442-38-2
AT7519 is a selective inhibitor of certain Cyclin Dependent Kinases (CDKs) leading to tumour regression. It is developed by Astex for the treatment of solid tumours and haematological malignancies.
Kategori:
Cyclin-Dependent Kinases, antagonists & inhibitors
Target Protein:
Cyclin-dependent kinase 2Cyclin-dependent kinase 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik
-
biotech | CAS: 1422959-91-8
Golodirsen is a morpholino antisense oligomer designed to treat about 8% of patients with Duchenne Muscular Dystrophy (DMD). This is an X-linked condition leading to progressive muscle degeneration that begins in early childhood, rendering many patients wheel…
Kategori:
Antisense Elements (Genetics)Antisense OligonucleotidesCompounds used in a research, industrial, or household setting
+10
Target Protein:
Dystrophin
Waktu ParuhIn a pharmacokineti…
Vol. DistribusiThe volume of distr…
KlirensThis drug is rapidl…
Genetik
-